Yahoo Finance3d
Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that ...
Investing3d
Gyre Therapeutics gears up for new lung injury trial
With the new trial, Gyre aims to explore the drug’s potential in mitigating lung injury progression in cancer patients. The company’s impressive 96% gross profit margin and healthy current ...
American Association of Individual Investors4d
Why Gyre Therapeutics, Inc.’s (GYRE) Stock Is Down 14.60%
Gyre Therapeutics, Inc.’s current stock price and volume Why Gyre Therapeutics, Inc.’s stock price changed recently Upgrades and downgrades for GYRE from analysts GYRE’s stock price momentum as ...
The New York Times4d
World News
New tremors rattled survivors of Friday’s earthquake, which killed more than 1,600 people, while the government continued its bombing campaign elsewhere in the country. By Sui-Lee Wee ...
Current2d
Current - For people in public media
Democratic state Sen. Brad Hoylman-Sigal sponsored a bill to allow public television and radio stations to claim an existing tax credit for newspapers and broadcasters. Blue Ridge Public Radio hired ...
Billboard6d
Top Current Album Sales
THE WEEK'S TOP-SELLING CURRENT ALBUMS (LESS THAN 18 MONTHS OLD) ACROSS ALL GENRES, AS COMPILED BY LUMINATE. LE SSERAFIM New this week! SOURCE/Geffen/ICLG Highest ranking debut Gains In Performance ...